From: New insights into the function of Interleukin-25 in disease pathogenesis
Comparative targets | IL-25 | IL-17A | References | |
---|---|---|---|---|
Biological Features | Homology | The homology of IL-25 to IL-17A is 16%. | ||
Form of generation | In the form of disulfide-linked dimers. | |||
Cellular sources | Th2 cells, mast cells, macrophages, etc. | Th17 cells | ||
Factors associated with signalling pathways | IL-17RA | The co-receptor | ||
TRAF6 | Participate in the activation of the NF-κB pathway. | |||
Act1 | Be recruited into IL-25 and IL-17A related signalling pathways. | |||
TRAF4 | Mediate signaling downstream. | Compete with TRAF6 for the TRAF binding domain on Act1 | ||
Performance in different diseases | Psoriasis | Participate in promoting psoriasis progression. | ||
Contact hypersensitivity | IL-25 promotes higher IL-17A expression | [44] | ||
Experimental autoimmune encephalomyelitis | IL-25 could work as a receptor antagonist of IL-17A function. | [59] | ||
Rheumatoid arthritis | [60] |